Risk of Dilution in Share Value from the Issuance of Stock Acquisition Rights and Other Instruments
First written in FY2017. 11 of 12 entries say "Materialised", first in FY2018. Latest entry: FY2025.
Temona. moved to the "Worse" side of this theme in 2018, 2 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
70 other companies' latest entry also says "Materialised".
- FY2025MaterialisedAnnual report
「Increase due to the exercise of stock acquisition rights 13,328 shares」
13,328 shares were actually issued through the exercise of stock acquisition rights, causing an additional potential equity value dilution factor to materialize. - FY2023MaterialisedAnnual report
「Increase resulting from the exercise of stock acquisition rights: 20,000 shares」
20,000 shares were actually issued through the exercise of stock acquisition rights, causing an additional potential equity value dilution factor to materialize. - FY2022-Q3MaterialisedAnnual report
「Change in total number of issued shares: 16,000 shares (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
16,000 shares were actually issued through the exercise of stock acquisition rights, causing an additional potential equity value dilution factor to materialize. - FY2022-Q2MaterialisedAnnual report
「At a meeting of the Board of Directors held on 25 March 2022, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights as stock options to its employees, and issued them on 15 April 2022.」
Stock acquisition rights for employees were issued, adding a potential dilution factor of up to 400,000 shares. Because this does not involve the exercise of stock acquisition rights itself, it is distinct from dilution resulting from the actual issuance of shares. - FY2021MaterialisedAnnual report
「1 October 2020–30 September 2021 133,544 (Note) 3. Increase due to the exercise of stock acquisition rights.」
The number of shares outstanding increased by 133,544 during the fiscal year through the exercise of stock acquisition rights, causing additional dilution factors to materialize. - FY2020MaterialisedAnnual report
「Increase due to the exercise of stock acquisition rights 261,144 shares」
The number of shares outstanding increased by 261,144 during the period through the exercise of stock acquisition rights, causing additional potential dilution factors to materialize. - FY2020-Q1MaterialisedAnnual report
「1 October 2019–31 December 2019 Change in total number of shares outstanding: 218,336 shares (Note) Increase due to the exercise of stock acquisition rights.」
The number of shares outstanding increased by 218,336 during the quarter through the exercise of stock acquisition rights, causing additional potential dilution factors to materialize. - FY2019MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares outstanding increased by 174,304 during the fiscal year through the exercise of stock acquisition rights, causing additional dilution factors to materialize. - FY2019-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares outstanding increased by 128,712 from January through March 2019 through the exercise of stock acquisition rights, causing additional dilution factors to materialize. - FY2019-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares outstanding actually increased by 45,592 through the exercise of stock acquisition rights, causing additional potential equity value dilution factors to materialize. - FY2018MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares outstanding actually increased through the exercise of stock acquisition rights, causing some of the potential equity value dilution factors to materialize. - FY2017First statedAnnual report
「We may issue stock acquisition rights, new shares or bonds with stock acquisition rights in the future, and their issuance and exercise could dilute the value of our shares on a per-share basis.」
The company describes the possibility that the issuance and exercise of stock options and other instruments may dilute equity value per share.